首页> 外国专利> process for the production of 18f radiolabeled nitroimidazole derivatives for the detection of cellular hypoxia

process for the production of 18f radiolabeled nitroimidazole derivatives for the detection of cellular hypoxia

机译:[18f]放射性标记的硝基咪唑衍生物的生产方法,用于检测细胞缺氧

摘要

The present invention relates to chemical synthesis of radiolabelled perfluorinated bioactive compounds. More particularly, the present invention relates to radiolabelled compounds to be used as indicators for tissue hypoxia. More particularly, the present invention relates to the synthesis and the use of [SUP18/SUPF] labelled perfluorinated nitroimidazole compounds having an incorporation of [SUP18/SUPF] atoms characterized by a specific radioactivity of the compound comprised between 1 and 30 Ci/mmol, preferably between 1 and 20 Ci/mmol, preferably 1 and 10 Ci/mmol. More particularly to [SUP18/SUPF] labelled EF3 or [SUP18/SUPF] labelled EF5. The present invention also relates to a method for the detection of tissue hypoxia in a patient comprising introducing an [SUP18/SUPF] labelled nitroimidazole compound into said patient, imaging tissue hypoxia in said patient, and, quantifying tissue hypoxia in said patient.
机译:本发明涉及放射性标记的全氟化生物活性化合物的化学合成。更具体地,本发明涉及用作组织缺氧指示剂的放射性标记化合物。更具体地,本发明涉及[ 18 F]标记的具有并入[ 18 F]原子的全氟化硝基咪唑化合物的合成和用途,该化合物的特征在于特定的放射性化合物的C 1含量为1-30Ci / mmol,优选1-20Ci / mmol,优选1-10Ci / mmol。更具体地说,标记为[3]的[ 18 F]或标记为EF5的[ 18 F]。本发明还涉及一种用于检测患者的组织缺氧的方法,该方法包括将[ 18 F]标记的硝基咪唑化合物引入所述患者,对所述患者的组织缺氧进行成像,以及量化组织缺氧。在所说的病人中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号